EPO and neoplasm: Tumor cells promote angiogenic activity through increases in hypoxia-inducible factor 1α (HIF-1α), vascular endothelial growth factor (VEGF), erythropoietin (EPO), cyclin D1 protein expression, which are essential for tumor growth.